The Food and Drug Administration (FDA) has approved updates to the Orbera Intragastric Balloon System (Apollo Endosurgery, Inc.) labeling to improve patient safety.
To learn more about weight-neutral diabetes care, Endocrinology Advisor checked in with experts in the field to discuss existing research and takeaways for clinicians.
Can a weight-neutral approach improve care for patients with diabetes?
Reflux symptoms return in about half of patients who undergo gastric bypass.
Pregnancy hyperglycemia at levels below the threshold for gestational diabetes mellitus (GDM) and maternal obesity are associated with childhood obesity.
Findings showed a legacy effect of participation in the behavioral weight loss intervention that led to reduced reward-related activity and enhanced attention and visual processing in response to high-calorie food cues.
Treatment with empagliflozin may reduce liver fat content and increase serum adiponectin in patients with well-controlled type 2 diabetes.
Type 2 diabetes mellitus (T2DM) is a risk factor for progression of liver fibrosis in patients with nonalcoholic fatty liver disease.
Results showed vinopocetine decreased fetal weight and increased the chance for miscarriage in pregnant animals.
Teasing in youth with or at risk for overweight associated with greater gain in BMI and fat mass
Adolescents are more likely to have remission of diabetes and hypertension after bariatric surgery compared with adults.